Biotech Imugene ‘encouraged’ by data for HER2 vaccine in gastric cancer
An early stage drug tested in a new study shows promising results for gastric cancer patients.
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org